 |
Prescription and Over-the-Counter Drug Product List
25th Edition
Cumulative Supplement Number 3: March 2006
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> + MIKART 300MG;7.5MG N40556 002 Mar 24, 2006 Mar NEWA
>D> HY-PHEN
>D> AA ASCHER 500MG;5MG N87677 001 May 03, 1982 Mar DISC
>A> @ 500MG;5MG N87677 001 May 03, 1982 Mar DISC
ACETAZOLAMIDE
TABLET; ORAL
ACETAZOLAMIDE
>D> AB TARO 250MG N40195 002 May 28, 1997 Mar CRLD
>A> AB + 250MG N40195 002 May 28, 1997 Mar CRLD
>D> DIAMOX
>D> AB DURAMED PHARMS 125MG N08943 001 Mar DISC
>A> @ 125MG N08943 001 Mar DISC
>D> AB + 250MG N08943 002 Mar DISC
>A> @ 250MG N08943 002 Mar DISC
ALBUTEROL SULFATE
SOLUTION; INHALATION
ALBUTEROL SULFATE
>A> AN RXELITE EQ 0.083% BASE N77569 001 Apr 04, 2006 Mar NEWA
AMOXICILLIN
TABLET; ORAL
AMOXICILLIN
>A> AB HIKMA 875MG N65255 001 Mar 29, 2006 Mar NEWA
ARTICAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE; INJECTION
>A> SEPTOCAINE
>A> DEPROCO 4%;EQ 0.005MG BASE/ML N22010 001 Mar 30, 2006 Mar NEWA
>D> + 4%;EQ 0.01MG BASE/ML N20971 001 Apr 03, 2000 Mar CPOT
>A> + 4%; EQ 0.017MG BASE/1.7ML (4%; EQ N20971 001 Apr 03, 2000 Mar CPOT
>D> BENZQUINAMIDE HYDROCHLORIDE
>D> INJECTABLE; INJECTION
>D> EMETE-CON
>D> + PFIZER EQ 50MG BASE/VIAL N16820 001 Mar DISC
>A> @ EQ 50MG BASE/VIAL N16820 001 Mar DISC
BUDESONIDE
SPRAY, METERED; NASAL
RHINOCORT
>D> ASTRAZENECA 0.032MG/INH N20746 001 Oct 01, 1999 Mar CRLD
>A> + 0.032MG/INH N20746 001 Oct 01, 1999 Mar CRLD
>D> + 0.064MG/INH N20746 002 Oct 01, 1999 Mar DISC
>A> @ 0.064MG/INH N20746 002 Oct 01, 1999 Mar DISC
CALCITRIOL
CAPSULE; ORAL
CALCITRIOL
>A> AB ROXANE 0.25UGM N76917 001 Mar 27, 2006 Mar NEWA
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL
CEFADROXIL
>D> AB IVAX PHARMS EQ 500MG BASE N62766 001 Mar 03, 1987 Mar CRLD
>A> AB + EQ 500MG BASE N62766 001 Mar 03, 1987 Mar CRLD
TABLET; ORAL
CEFADROXIL
>A> AB HIKMA EQ 1GM BASE N65260 001 Mar 30, 2006 Mar NEWA
CEFUROXIME AXETIL
TABLET; ORAL
CEFUROXIME AXETIL
>A> AB AUROBINDO PHARMA EQ 125MG BASE N65308 001 Mar 29, 2006 Mar NEWA
>A> AB EQ 250MG BASE N65308 002 Mar 29, 2006 Mar NEWA
>A> AB EQ 500MG BASE N65308 003 Mar 29, 2006 Mar NEWA
CEPHRADINE
CAPSULE; ORAL
ANSPOR
>D> AB GLAXOSMITHKLINE 250MG N61859 001 Mar DISC
>A> @ 250MG N61859 001 Mar DISC
>D> AB 500MG N61859 002 Mar DISC
>A> @ 500MG N61859 002 Mar DISC
CICLOPIROX
CREAM; TOPICAL
CICLOPIROX
>A> AB PERRIGO 0.77% N77364 001 Mar 03, 2006 Mar CAHN
>D> AB PERRIGO NEW YORK 0.77% N77364 001 Mar 03, 2006 Mar CAHN
CILOSTAZOL
TABLET; ORAL
CILOSTAZOL
>A> AB MUTUAL PHARM 50MG N77208 002 Mar 29, 2006 Mar NEWA
>A> AB 100MG N77208 001 Mar 29, 2006 Mar NEWA
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>A> AB TARO EQ 10MG BASE N77278 001 Mar 22, 2006 Mar NEWA
>A> AB EQ 20MG BASE N77278 002 Mar 22, 2006 Mar NEWA
>A> AB EQ 40MG BASE N77278 003 Mar 22, 2006 Mar NEWA
>A> AB TEVA PHARMS EQ 10MG BASE N77213 001 Mar 31, 2006 Mar NEWA
>A> AB EQ 20MG BASE N77213 002 Mar 31, 2006 Mar NEWA
>A> AB EQ 40MG BASE N77213 003 Mar 31, 2006 Mar NEWA
CYANOCOBALAMIN
>D> GEL, METERED; NASAL
>D> NASCOBAL
>D> + QOL MEDCL 0.5MG/INH N19722 001 Nov 05, 1996 Mar DISC
>A> @ 0.5MG/INH N19722 001 Nov 05, 1996 Mar DISC
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
>A> AB MUTUAL PHARM 5MG N73541 002 Apr 06, 2006 Mar NEWA
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION
DEFEROXAMINE MESYLATE
>A> AP SICOR PHARMS 500MG/VIAL N76806 001 Mar 31, 2006 Mar NEWA
>A> AP 2GM/VIAL N76806 002 Mar 31, 2006 Mar NEWA
DEMECLOCYCLINE HYDROCHLORIDE
TABLET; ORAL
DECLOMYCIN
>A> @ GLADES PHARMS LLC 75MG N50261 001 Mar CAHN
>A> AB 150MG N50261 002 Mar CAHN
>A> AB + 300MG N50261 003 Mar CAHN
>D> @ PROTEIN DESIGN 75MG N50261 001 Mar CAHN
>D> AB 150MG N50261 002 Mar CAHN
>D> AB + 300MG N50261 003 Mar CAHN
DEXAMETHASONE SODIUM PHOSPHATE
INJECTABLE; INJECTION
DEXAMETHASONE
>A> AP BAXTER HLTHCARE EQ 10MG PHOSPHATE/ML N87702 001 Sep 07, 1982 Mar CAHN
>D> AP ELKINS SINN EQ 10MG PHOSPHATE/ML N87702 001 Sep 07, 1982 Mar CAHN
DIAZEPAM
TABLET; ORAL
DIAZEPAM
>A> AB VINTAGE PHARMS 2MG N77749 001 Mar 31, 2006 Mar NEWA
>A> AB 5MG N77749 002 Mar 31, 2006 Mar NEWA
>A> AB 10MG N77749 003 Mar 31, 2006 Mar NEWA
>A> DOLASETRON MESYLATE
>A> INJECTABLE; INJECTION
>A> ANZEMET
>A> + SANOFI AVENTIS US EQ 12.5MG BASE/0.625ML (EQ 20MG N20624 002 Sep 11, 1997 Mar CAIN
>A> + EQ 100MG BASE/5ML (EQ 20MG BASE/ML) N20624 001 Sep 11, 1997 Mar CAIN
>A> + EQ 500MG BASE/25ML (EQ 20MG N20624 003 Dec 11, 2001 Mar CAIN
>A> TABLET; ORAL
>A> ANZEMET
>A> SANOFI AVENTIS US EQ 50MG BASE N20623 001 Sep 11, 1997 Mar CAIN
>A> + EQ 100MG BASE N20623 002 Sep 11, 1997 Mar CAIN
>D> DOLASETRON MESYLATE MONOHYDRATE
>D> INJECTABLE; INJECTION
>D> ANZEMET
>D> SANOFI AVENTIS US EQ 12.5MG BASE/0.625ML N20624 002 Sep 11, 1997 Mar CAIN
>D> + EQ 100MG BASE/5ML N20624 001 Sep 11, 1997 Mar CAIN
>D> + EQ 500MG BASE/25ML N20624 003 Dec 11, 2001 Mar CAIN
>D> TABLET; ORAL
>D> ANZEMET
>D> SANOFI AVENTIS US EQ 50MG BASE N20623 001 Sep 11, 1997 Mar CAIN
>D> + EQ 100MG BASE N20623 002 Sep 11, 1997 Mar CAIN
DOXYCYCLINE
CAPSULE; ORAL
DOXYCYCLINE
>D> AB PAR PHARM EQ 75MG BASE N65055 004 Apr 18, 2005 Mar DISC
>A> @ EQ 75MG BASE N65055 004 Apr 18, 2005 Mar DISC
>D> EQ 150MG BASE N65055 003 Jul 15, 2005 Mar DISC
>A> @ EQ 150MG BASE N65055 003 Jul 15, 2005 Mar DISC
>D> AB RANBAXY EQ 75MG BASE N65053 003 Sep 10, 2003 Mar CTEC
>A> EQ 75MG BASE N65053 003 Sep 10, 2003 Mar CTEC
TABLET; ORAL
DOXYCYCLINE
>D> @ PAR PHARM EQ 75MG BASE N65070 003 Dec 30, 2002 Mar CMFD
>A> EQ 75MG BASE N65070 003 Dec 30, 2002 Mar CMFD
DROSPIRENONE; ETHINYL ESTRADIOL
TABLET; ORAL
>A> YAZ
>A> + BERLEX LABS 3MG;0.02MG N21676 001 Mar 16, 2006 Mar NEWA
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE W/ EPINEPHRINE
>D> DENTSPLY PHARM 0.02MG/ML;2% N21381 002 Mar CRLD
>A> + 0.02MG/ML;2% N21381 002 Mar CRLD
ESTROGENS, CONJUGATED SYNTHETIC B
TABLET; ORAL
ENJUVIA
>D> @ DURAMED 0.3MG N21443 001 Dec 20, 2004 Mar CMFD
>A> 0.3MG N21443 001 Dec 20, 2004 Mar CMFD
>D> @ 0.45MG N21443 002 Dec 20, 2004 Mar CMFD
>A> 0.45MG N21443 002 Dec 20, 2004 Mar CMFD
>D> @ 0.625MG N21443 003 May 10, 2004 Mar CMFD
>A> 0.625MG N21443 003 May 10, 2004 Mar CMFD
>D> @ 1.25MG N21443 004 May 10, 2004 Mar CMFD
>A> + 1.25MG N21443 004 May 10, 2004 Mar CMFD
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET; ORAL-21
BALZIVA-21
>D> + BARR 0.035MG;0.4MG N76198 001 Apr 22, 2004 Mar CRLD
>A> 0.035MG;0.4MG N76198 001 Apr 22, 2004 Mar CRLD
TABLET; ORAL-28
OVCON-35
>D> AB WARNER CHILCOTT 0.035MG;0.4MG N17716 001 Mar CRLD
>A> AB + 0.035MG;0.4MG N17716 001 Mar CRLD
ETODOLAC
CAPSULE; ORAL
ETODOLAC
>D> AB TARO 300MG N75078 002 Apr 30, 1998 Mar CRLD
>A> AB + 300MG N75078 002 Apr 30, 1998 Mar CRLD
>D> LODINE
>D> AB + WYETH PHARMS INC 300MG N18922 003 Jan 31, 1991 Mar DISC
>A> @ 300MG N18922 003 Jan 31, 1991 Mar DISC
FENTANYL CITRATE
TROCHE/LOZENGE; TRANSMUCOSAL
>D> ACTIQ
>D> CEPHALON EQ 0.2MG BASE N20747 001 Nov 04, 1998 Mar CTNA
>D> + EQ 0.4MG BASE N20747 002 Nov 04, 1998 Mar CTNA
>D> EQ 0.6MG BASE N20747 003 Nov 04, 1998 Mar CTNA
>D> EQ 0.8MG BASE N20747 004 Nov 04, 1998 Mar CTNA
>D> EQ 1.2MG BASE N20747 005 Nov 04, 1998 Mar CTNA
>D> EQ 1.6MG BASE N20747 006 Nov 04, 1998 Mar CTNA
>A> ACTIQ (SUGAR-FREE)
>A> CEPHALON EQ 0.2MG BASE N20747 001 Nov 04, 1998 Mar CTNA
>A> + EQ 0.4MG BASE N20747 002 Nov 04, 1998 Mar CTNA
>A> EQ 0.6MG BASE N20747 003 Nov 04, 1998 Mar CTNA
>A> EQ 0.8MG BASE N20747 004 Nov 04, 1998 Mar CTNA
>A> EQ 1.2MG BASE N20747 005 Nov 04, 1998 Mar CTNA
>A> EQ 1.6MG BASE N20747 006 Nov 04, 1998 Mar CTNA
FEXOFENADINE HYDROCHLORIDE
TABLET; ORAL
FEXOFENADINE HYDROCHLORIDE
>A> AB DR REDDYS LABS 30MG N76502 001 Apr 11, 2006 Mar NEWA
>A> AB 60MG N76502 002 Apr 11, 2006 Mar NEWA
>A> AB 180MG N76502 003 Apr 11, 2006 Mar NEWA
FLUORESCEIN SODIUM
>A> INJECTABLE; INTRAVENOUS
>A> FLUORESCITE
>A> + ALCON RES EQ 500MG BASE/5ML (EQ 100MG N21980 001 Mar 28, 2006 Mar NEWA
FLUOROURACIL
INJECTABLE; INJECTION
ADRUCIL
>D> AP SICOR PHARMS 50MG/ML N40023 001 Oct 18, 1991 Mar CRLD
>A> AP + 50MG/ML N40023 001 Oct 18, 1991 Mar CRLD
FLUOROURACIL
>D> AP AM PHARM 50MG/ML N40291 001 Mar 24, 1999 Mar CRLD
>D> AP AM PHARM 50MG/ML N40379 001 Nov 15, 2000 Mar CRLD
>A> AP + 50MG/ML N40379 001 Nov 15, 2000 Mar CRLD
>A> AP + 50MG/ML N40291 001 Mar 24, 1999 Mar CRLD
>D> AP 50MG/ML N40279 001 Sep 30, 1998 Mar CRLD
>A> AP + 50MG/ML N40279 001 Sep 30, 1998 Mar CRLD
>D> AP 50MG/ML N40278 001 Sep 30, 1998 Mar CRLD
>A> AP + 50MG/ML N40278 001 Sep 30, 1998 Mar CRLD
>D> AP BEDFORD 50MG/ML N89508 001 Jan 26, 1988 Mar CRLD
>A> AP + 50MG/ML N89508 001 Jan 26, 1988 Mar CRLD
>D> AP SICOR PHARMS 50MG/ML N40334 001 Feb 25, 2000 Mar CRLD
>A> AP + 50MG/ML N40334 001 Feb 25, 2000 Mar CRLD
>D> AP 50MG/ML N40333 001 Jan 27, 2000 Mar CRLD
>A> AP + 50MG/ML N40333 001 Jan 27, 2000 Mar CRLD
>D> AP STERIS 50MG/ML N87792 001 Oct 13, 1982 Mar CRLD
>A> AP + 50MG/ML N87792 001 Oct 13, 1982 Mar CRLD
FLUVOXAMINE MALEATE
TABLET; ORAL
FLUVOXAMINE MALEATE
>A> AB LEINER 25MG N75888 001 Nov 29, 2000 Mar CAHN
>A> AB 50MG N75888 002 Nov 29, 2000 Mar CAHN
>A> AB + 100MG N75888 003 Nov 29, 2000 Mar CAHN
>D> AB SANDOZ 25MG N75888 001 Nov 29, 2000 Mar CAHN
>D> AB 50MG N75888 002 Nov 29, 2000 Mar CAHN
>D> AB + 100MG N75888 003 Nov 29, 2000 Mar CAHN
GLIPIZIDE
TABLET, EXTENDED RELEASE; ORAL
GLIPIZIDE
>A> AB WATSON LABS 2.5MG N76467 003 Mar 27, 2006 Mar NEWA
GLUCOTROL XL
>D> PFIZER 2.5MG N20329 003 Aug 10, 1999 Mar CFTG
>A> AB 2.5MG N20329 003 Aug 10, 1999 Mar CFTG
HALOBETASOL PROPIONATE
OINTMENT; TOPICAL
HALOBETASOL PROPIONATE
>D> AB AGIS INDS 0.05% N76872 001 Dec 16, 2004 Mar CAHN
>A> AB PERRIGO 0.05% N76872 001 Dec 16, 2004 Mar CAHN
HYDROCORTISONE SODIUM SUCCINATE
INJECTABLE; INJECTION
A-HYDROCORT
>A> AP HOSPIRA EQ 100MG BASE/VIAL N40666 001 Apr 06, 2006 Mar NEWA
HYDROXYZINE PAMOATE
CAPSULE; ORAL
HYDROXYZINE PAMOATE
>D> AB BARR EQ 100MG HCL N88488 001 Jun 15, 1984 Mar CTEC
>A> EQ 100MG HCL N88488 001 Jun 15, 1984 Mar CTEC
VISTARIL
>D> AB PFIZER EQ 100MG HCL N11459 006 Mar DISC
>A> @ EQ 100MG HCL N11459 006 Mar DISC
INSULIN GLULISINE RECOMBINANT
INJECTABLE; SUBCUTANEOUS
APIDRA
>D> @ SANOFI AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) N21629 001 Apr 16, 2004 Mar CMFD
>A> + 1000 UNITS/10ML (100 UNITS/ML) N21629 001 Apr 16, 2004 Mar CMFD
>D> @ 300 UNITS/3ML (100 UNITS/ML) N21629 002 Dec 20, 2005 Mar CMFD
>A> + 300 UNITS/3ML (100 UNITS/ML) N21629 002 Dec 20, 2005 Mar CMFD
ISOSORBIDE MONONITRATE
TABLET, EXTENDED RELEASE; ORAL
ISOSORBIDE MONONITRATE
>A> AB WEST WARD 30MG N76813 002 Mar 30, 2006 Mar NEWA
LEVETIRACETAM
TABLET; ORAL
KEPPRA
>D> + UCB INC 750MG N21035 003 Nov 30, 1999 Mar CRLD
>A> 750MG N21035 003 Nov 30, 1999 Mar CRLD
>A> + 1GM N21035 004 Jan 06, 2006 Mar NEWA
LORAZEPAM
TABLET; ORAL
LORAZEPAM
>A> AB MYLAN 0.5MG N77657 001 Mar 16, 2006 Mar NEWA
>A> AB 1MG N77657 002 Mar 16, 2006 Mar NEWA
>A> AB 2MG N77657 003 Mar 16, 2006 Mar NEWA
>A> MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE
>A> TABLET, CHEWABLE; ORAL
>A> ZEGERID
>A> SANTARUS 700MG;20MG;600MG N21850 001 Mar 24, 2006 Mar NEWA
>A> + 700MG;40MG;600MG N21850 002 Mar 24, 2006 Mar NEWA
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HYDROCHLORIDE
>D> AP HOSPIRA EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Mar CRLD
>A> AP + EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Mar CRLD
MITOXANTRONE HYDROCHLORIDE
INJECTABLE; INJECTION
>A> MITOXANTRONE
>A> AP AM PHARM EQ 20MG BASE/10ML (2MG/ML) N77496 001 Apr 11, 2006 Mar NEWA
>A> AP EQ 25MG BASE/12.5ML (2MG/ML) N77496 002 Apr 11, 2006 Mar NEWA
>A> AP EQ 30MG BASE/15ML (2MG/ML) N77496 003 Apr 11, 2006 Mar NEWA
>A> AP BEDFORD EQ 20MG BASE/10ML (2MG/ML) N76611 001 Apr 11, 2006 Mar NEWA
>A> AP EQ 25MG BASE/12.5ML (2MG/ML) N76611 002 Apr 11, 2006 Mar NEWA
>A> AP EQ 30MG BASE/15ML (2MG/ML) N76611 003 Apr 11, 2006 Mar NEWA
>A> AP MAYNE PHARMA USA EQ 20MG BASE/10ML (2MG/ML) N76871 001 Apr 11, 2006 Mar NEWA
>A> AP EQ 25MG BASE/12.5ML (2MG/ML) N76871 002 Apr 11, 2006 Mar NEWA
>A> AP EQ 30MG BASE/15ML (2MG/ML) N76871 003 Apr 11, 2006 Mar NEWA
>A> AP SICOR PHARMS EQ 20MG BASE/10ML (2MG/ML) N77356 001 Apr 11, 2006 Mar NEWA
>A> AP EQ 25MG BASE/12.5ML (2MG/ML) N77356 002 Apr 11, 2006 Mar NEWA
>A> AP EQ 30MG BASE/15ML (2MG/ML) N77356 003 Apr 11, 2006 Mar NEWA
NOVANTRONE
>D> + SERONO INC EQ 20MG BASE/10 MG (2MG/ML) N19297 001 Dec 23, 1987 Mar CFTG
>A> AP + EQ 20MG BASE/10ML(2MG/ML) N19297 001 Dec 23, 1987 Mar CFTG
>D> + EQ 25MG BASE/12.5ML (2MG/ML) N19297 002 Dec 23, 1987 Mar CFTG
>A> AP + EQ 25MG BASE/12.5ML (2MG/ML) N19297 002 Dec 23, 1987 Mar CFTG
>D> + EQ 30MG BASE/15ML (2MG/ML) N19297 003 Dec 23, 1987 Mar CFTG
>A> AP + EQ 30MG BASE/15ML (2MG/ML) N19297 003 Dec 23, 1987 Mar CFTG
MOMETASONE FUROATE
LOTION; TOPICAL
MOMETASONE FUROATE
>D> AB AGIS INDS 0.1% N77180 001 Apr 06, 2005 Mar CAHN
>A> AB PERRIGO 0.1% N77180 001 Apr 06, 2005 Mar CAHN
MORPHINE SULFATE
INJECTABLE; INJECTION
MORPHINE SULFATE
>A> HOSPIRA 5MG/ML N19916 002 Mar 30, 2006 Mar NEWA
PILOCARPINE HYDROCHLORIDE
TABLET; ORAL
PILOCARPINE HYDROCHLORIDE
>A> AB IMPAX LABS 5MG N77248 001 Mar 31, 2006 Mar NEWA
>A> AB 7.5MG N77248 002 Mar 31, 2006 Mar NEWA
SALAGEN
>D> + MGI PHARMA INC 7.5MG N20237 002 Apr 18, 2003 Mar CFTG
>A> AB + 7.5MG N20237 002 Apr 18, 2003 Mar CFTG
PREDNISOLONE ACETATE
>D> INJECTABLE; INJECTION
>D> PREDNISOLONE ACETATE
>D> + STERIS 25MG/ML N83398 001 Mar DISC
>A> @ 25MG/ML N83398 001 Mar DISC
>D> + 50MG/ML N83764 001 Mar DISC
>A> @ 50MG/ML N83764 001 Mar DISC
PROMETHAZINE HYDROCHLORIDE
SUPPOSITORY; RECTAL
>D> PHENERGAN
>D> AB WYETH PHARMS INC 12.5MG N10926 002 Mar DISC
>A> @ 12.5MG N10926 002 Mar DISC
>D> AB + 25MG N10926 001 Mar DISC
>A> @ 25MG N10926 001 Mar DISC
PROMETHAZINE HYDROCHLORIDE
>D> AB G AND W LABS 25MG N40428 001 Feb 05, 2002 Mar CRLD
>A> AB + 25MG N40428 001 Feb 05, 2002 Mar CRLD
PROPOFOL
INJECTABLE; INJECTION
PROPOFOL
>A> AB HOSPIRA 10MG/ML N77908 001 Mar 17, 2006 Mar NEWA
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
PROPOXYPHENE HYDROCHLORIDE
>D> AA IVAX PHARMS 65MG N80269 001 Mar CAHN
>A> AA PAR PHARM 65MG N80269 001 Mar CAHN
RISPERIDONE
TABLET, ORALLY DISINTEGRATING; ORAL
RISPERDAL
>D> @ JANSSEN PHARMA 3MG N21444 004 Dec 23, 2004 Mar CMFD
>A> 3MG N21444 004 Dec 23, 2004 Mar CMFD
>D> @ 4MG N21444 005 Dec 23, 2004 Mar CMFD
>A> 4MG N21444 005 Dec 23, 2004 Mar CMFD
>A> SELEGILINE
>A> FILM, EXTENDED RELEASE; TRANSDERMAL
>A> EMSAM
>A> SOMERSET 6MG/24HR N21336 001 Feb 27, 2006 Mar CAIN
>A> 9MG/24HR N21336 002 Feb 27, 2006 Mar CAIN
>A> + 12MG/24HR N21336 003 Feb 27, 2006 Mar CAIN
>D> SELEGILINE HYDROCHLORIDE
>D> FILM, EXTENDED RELEASE; TRANSDERMAL
>D> EMSAM
>D> SOMERSET 6MG/24HR N21336 001 Feb 27, 2006 Mar CAIN
>D> 9MG/24HR N21336 002 Feb 27, 2006 Mar CAIN
>D> + 12MG/24HR N21336 003 Feb 27, 2006 Mar CAIN
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TABLET; ORAL
>A> OSMOPREP
>A> + SALIX PHARMS 0.398GM;1.102GM N21892 001 Mar 16, 2006 Mar NEWA
TERCONAZOLE
SUPPOSITORY; VAGINAL
TERAZOL 3
>D> + ORTHO MCNEIL 80MG N19641 001 May 24, 1988 Mar CFTG
>A> AB + 80MG N19641 001 May 24, 1988 Mar CFTG
>A> TERCONAZOLE
>A> AB PERRIGO NEW YORK 80MG N77149 001 Mar 17, 2006 Mar NEWA
>D> TROLEANDOMYCIN
>D> CAPSULE; ORAL
>D> TAO
>D> + PFIZER EQ 250MG BASE N50336 002 Mar DISC
>A> @ EQ 250MG BASE N50336 002 Mar DISC
ZIDOVUDINE
CAPSULE; ORAL
RETROVIR
>D> + GLAXOSMITHKLINE 100MG N19655 001 Mar 19, 1987 Mar CFTG
>A> AB + 100MG N19655 001 Mar 19, 1987 Mar CFTG
>A> ZIDOVUDINE
>A> AB AUROBINDO PHARMA 100MG N78128 001 Mar 27, 2006 Mar NEWA
ZIPRASIDONE HYDROCHLORIDE
>A> SUSPENSION; ORAL
>A> GEODON
>A> + PFIZER INC EQ 10MG BASE/ML N21483 001 Mar 29, 2006 Mar NEWA
ZONISAMIDE
CAPSULE; ORAL
ZONISAMIDE
>A> AB SUN PHARM INDS (IN) 25MG N77634 001 Mar 17, 2006 Mar NEWA
>A> AB 50MG N77634 002 Mar 17, 2006 Mar NEWA
>A> AB 100MG N77634 003 Mar 17, 2006 Mar NEWA
LOPERAMIDE HYDROCHLORIDE
>D> SOLUTION; ORAL
>D> IMODIUM A-D
>D> + MCNEIL 1MG/7.5ML N19487 002 Jul 08, 2004 Mar CDFR
>A> SUSPENSION; ORAL
>A> IMODIUM A-D
>A> + MCNEIL 1MG/7.5ML N19487 002 Jul 08, 2004 Mar CDFR
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
NICORETTE
>A> GLAXOSMITHKLINE EQ 2MG BASE N18612 003 Dec 23, 1998 Mar CRLD
>A> EQ 2MG BASE N18612 004 Sep 25, 2000 Mar CRLD
>A> EQ 4MG BASE N20066 003 Dec 23, 1998 Mar CRLD
>A> EQ 4MG BASE N20066 004 Sep 25, 2000 Mar CRLD
NICORETTE (MINT)
>D> + GLAXOSMITHKLINE EQ 2MG BASE N18612 003 Dec 23, 1998 Mar CRLD
>D> + EQ 4MG BASE N20066 003 Dec 23, 1998 Mar CRLD
NICORETTE (ORANGE)
>D> + GLAXOSMITHKLINE EQ 2MG BASE N18612 004 Sep 25, 2000 Mar CRLD
>D> + EQ 4MG BASE N20066 004 Sep 25, 2000 Mar CRLD
Date created: April 14, 2006 |
|
